BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cycle threshold (Ct) has been suggested as an approximate measure of initial viral burden. The utility of cycle threshold, at admission, as a predictor of disease severity has not been thoroughly investigated. METHODS AND FINDINGS: We conducted a retrospective study of SARS-CoV-2 positive, hospitalized patients from 3/26/2020 to 8/5/2020 who had SARS-CoV-2 Ct data within 48 hours of admission (n = 1044). Only patients with complete survival data, discharged (n = 774) or died in hospital (n = 270), were included in our analysis. Laboratory, demographic, and clinical data were extracted from electronic medical records. Multivariable logistic regression was applied to examine the relationship of patient mortality with Ct values while adjusting for established risk factors. Ct was analyzed as continuous variable and subdivided into quartiles to better illustrate its relationship with outcome. Cumulative incidence curves were created to assess whether there was a survival difference in the setting of the competing risks of death versus patient discharge. Mean Ct at admission was higher for survivors (28.6, SD = 5.8) compared to non-survivors (24.8, SD = 6.0, P<0.001). In-hospital mortality significantly differed (p<0.05) by Ct quartile. After adjusting for age, gender, BMI, hypertension and diabetes, increased cycle threshold was associated with decreased odds of in-hospital mortality (0.91, CI 0.89-0.94, p<0.001). Compared to the 4th Quartile, patients with Ct values in the 1st Quartile (Ct <22.9) and 2nd Quartile (Ct 23.0-27.3) had an adjusted odds ratio of in-hospital mortality of 3.8 and 2.6 respectively (p<0.001). The discriminative ability of Ct to predict inpatient mortality was found to be limited, possessing an area under the curve (AUC) of 0.68 (CI 0.63-0.71). CONCLUSION: SARS-CoV-2 Ct was found to be an independent predictor of patient mortality. However, further study is needed on how to best clinically utilize such information given the result variation due to specimen quality, phase of disease, and the limited discriminative ability of the test.
BACKGROUND:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cycle threshold (Ct) has been suggested as an approximate measure of initial viral burden. The utility of cycle threshold, at admission, as a predictor of disease severity has not been thoroughly investigated. METHODS AND FINDINGS: We conducted a retrospective study of SARS-CoV-2 positive, hospitalized patients from 3/26/2020 to 8/5/2020 who had SARS-CoV-2 Ct data within 48 hours of admission (n = 1044). Only patients with complete survival data, discharged (n = 774) or died in hospital (n = 270), were included in our analysis. Laboratory, demographic, and clinical data were extracted from electronic medical records. Multivariable logistic regression was applied to examine the relationship of patientmortality with Ct values while adjusting for established risk factors. Ct was analyzed as continuous variable and subdivided into quartiles to better illustrate its relationship with outcome. Cumulative incidence curves were created to assess whether there was a survival difference in the setting of the competing risks of death versus patient discharge. Mean Ct at admission was higher for survivors (28.6, SD = 5.8) compared to non-survivors (24.8, SD = 6.0, P<0.001). In-hospital mortality significantly differed (p<0.05) by Ct quartile. After adjusting for age, gender, BMI, hypertension and diabetes, increased cycle threshold was associated with decreased odds of in-hospital mortality (0.91, CI 0.89-0.94, p<0.001). Compared to the 4th Quartile, patients with Ct values in the 1st Quartile (Ct <22.9) and 2nd Quartile (Ct 23.0-27.3) had an adjusted odds ratio of in-hospital mortality of 3.8 and 2.6 respectively (p<0.001). The discriminative ability of Ct to predict inpatientmortality was found to be limited, possessing an area under the curve (AUC) of 0.68 (CI 0.63-0.71). CONCLUSION:SARS-CoV-2 Ct was found to be an independent predictor of patientmortality. However, further study is needed on how to best clinically utilize such information given the result variation due to specimen quality, phase of disease, and the limited discriminative ability of the test.
Authors: Martin Skarzynski; Erin M McAuley; Ezekiel J Maier; Anthony C Fries; Jameson D Voss; Richard R Chapleau Journal: Glob Health Epidemiol Genom Date: 2022-05-31
Authors: A Faycal; A L Ndoadoumgue; B Sellem; C Blanc; Y Dudoit; L Schneider; R Tubiana; M-A Valantin; S Seang; R Palich; A Bleibtreu; G Monsel; N Godefroy; O Itani; O Paccoud; V Pourcher; E Caumes; N Ktorza; A Chermak; B Abdi; L Assoumou; C Katlama Journal: Infect Dis Now Date: 2021-11-17
Authors: Martín Eduardo Brizuela; Sandra Elizabeth Goñi; Georgina Alexandra Cardama; María Alejandra Zinni; Alejandro Andres Castello; Leandro Matías Sommese; Hernán Gabriel Farina Journal: Front Pediatr Date: 2022-07-07 Impact factor: 3.569
Authors: Zuzana Dankova; Elena Novakova; Maria Skerenova; Veronika Holubekova; Vincent Lucansky; Dana Dvorska; Dusan Brany; Zuzana Kolkova; Jan Strnadel; Sandra Mersakova; Katarina Janikova; Marek Samec; Michal Pokusa; Martin Petras; Miroslava Sarlinova; Ivana Kasubova; Dusan Loderer; Vladimira Sadlonova; Jana Kompanikova; Nina Kotlebova; Adriana Kompanikova; Martina Hrnciarova; Andrea Stanclova; Martina Antosova; Anton Dzian; Vladimir Nosal; Ivan Kocan; Dalibor Murgas; Dusan Krkoska; Andrea Calkovska; Erika Halasova Journal: Int J Environ Res Public Health Date: 2021-07-01 Impact factor: 3.390
Authors: Jeremy Ratcliff; Farah Al-Beidh; Sagida Bibi; David Bonsall; Sue Ann Costa Clemens; Lise Estcourt; Amy Evans; Matthew Fish; Pedro M Folegatti; Anthony C Gordon; Cecilia Jay; Aislinn Jennings; Emma Laing; Teresa Lambe; George MacIntyre-Cockett; David Menon; Paul R Mouncey; Dung Nguyen; Andrew J Pollard; Maheshi N Ramasamy; David J Roberts; Kathryn M Rowan; Jennifer Rynne; Manu Shankar-Hari; Sarah Williams; Heli Harvala; Tanya Golubchik; Peter Simmonds Journal: J Clin Microbiol Date: 2022-03-24 Impact factor: 11.677